Syngenta's IPO is more relief than triumph : vimarsana.com

Syngenta’s $9 billion Chinese market listing finally looks ripe. Concerns about its share sale size forced the Switzerland-based agrichemical giant to opt for a last-minute venue change. Sadly, few foreign investors are likely to join its Shanghai debut party.

Related Keywords

Hong Kong , Shanghai , China , Beijing , Switzerland , London , City Of , United Kingdom , Shenzhen , Guangdong , Chinese , Eric Fyrwald , Lisa Jucca , Katrina Hamlin , Semiconductor Manufacturing International Corporation , Shanghai Stock Exchange , Twitter , Jiangsu Evergreen New Material Technology , Syngenta Group , Thomson Reuters Trust Principles , Syngenta , Reuters Breakingviews , Evergreen New Material Technology , Qualified Foreign Institutional Investor , Thomson Reuters Trust , Reuters News , Trust Principles , Brv , Mtgfx , Clm , Rep , Kagrc , Agrc1 , Anlins , Bact , Bisv , Bisv08 , Biz , Bmat , Bmat08 , Chem , Cmpny , Deal1 , Fin , Fine1 , Fins , Fins08 , Fobe , Fod , Invbis , Invs08 , Ipo , Isu , Mevn , Emrg , Ncyc , Privt , Pstcde , Xdnp , Xpco , Xrnp , Easia , Asxpac , Cn , Asia , Topnws , Brvf , Invm , Pve , Chen ,